Form 4: ACHIEVE LIFE SCIENCES Director Stuart Duty Granted 31,500 Stock Options
Insider Transaction Report
ACHIEVE LIFE SCIENCES, INC. Director Stuart Duty was granted 31,500 stock options with an exercise price of $3.83, vesting by June 2026.
Summary
- Stuart Duty, a Director of ACHIEVE LIFE SCIENCES, INC. (ACHV), reported the acquisition of derivative securities.
- The transaction involved the grant of 31,500 stock options to purchase common stock.
- The options have an exercise price of $3.83 per share.
- These options will vest 100% on the earlier of June 6, 2026, or the date immediately prior to the Issuer's 2026 annual meeting of stockholders.
- The expiration date for these stock options is June 6, 2035.
- Following this reported transaction, Stuart Duty beneficially owns 31,500 derivative securities directly.
Sentiment
Score: 6
Explanation: Slightly positive, as it indicates continued alignment of a director's interests with the company's performance through equity compensation, which is a standard and generally well-regarded practice.
Positives
- The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term performance.
- The options have a 10-year expiration period, providing a long-term incentive for the director.
Negatives
- The exercise of these options in the future could lead to a minor dilution of existing shares, though this is standard for equity compensation plans.
Future Outlook
The stock options granted to Director Stuart Duty are set to vest by June 2026, aligning his future financial incentives with the company's performance over the coming year.
Industry Context
This Form 4 filing reflects a routine equity compensation event for a director, a common practice across various industries to incentivize and retain key personnel by aligning their financial interests with shareholder value creation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Structure | Grant of 31,500 stock options to Director Stuart Duty as part of his compensation. | 06/06/2025 | Enhances alignment between director's incentives and shareholder value; standard practice in corporate governance for executive and director compensation. |
Related Party Transactions
- The grant of stock options from ACHIEVE LIFE SCIENCES, INC. to its Director, Stuart Duty, constitutes a related party transaction as it involves compensation provided by the company to an insider.
Stakeholder Impact
- Shareholders: Potential for minor future dilution if options are exercised, but also benefit from increased alignment of director's interests with company performance.
- Director (Stuart Duty): Receives equity-based compensation, aligning his personal financial success with the company's long-term stock performance.
Next Steps
- The stock options will vest 100% on the earlier of June 6, 2026, or the date immediately prior to the Issuer's 2026 annual meeting of stockholders.
- Stuart Duty may choose to exercise these options at any time after vesting and before the expiration date of June 6, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/06/2025 | Date of earliest transaction (grant date of stock options). |
| 06/10/2025 | Date the Form 4 was signed by Sandra Thomson as attorney-in-fact for Stuart Duty. |
| 06/06/2026 | Earliest vesting date for the stock options (100% vesting). |
| 2026 | Alternative vesting condition: date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
| 06/06/2035 | Expiration date of the stock options. |
Keywords
ACHIEVE LIFE SCIENCES, ACHV, Stock Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.